Succinic Semialdehyde Dehydrogenase DeficiencySymptoms, Doctors, Treatments, Advances & More
Succinic Semialdehyde Dehydrogenase Deficiency Overview
Learn About Succinic Semialdehyde Dehydrogenase Deficiency
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
C H Neurology Foundation Inc
Phillip Pearl is a Pediatrics provider practicing medicine in Boston, Massachusetts. Dr. Pearl is rated as an Elite provider by MediFind in the treatment of Succinic Semialdehyde Dehydrogenase Deficiency. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Succinic Semialdehyde Dehydrogenase Deficiency, Epilepsy, Epilepsy in Children, and Seizures. Dr. Pearl is board certified in Pediatrics, Neurology With Special Qualifications In Child Neurology, Clinical Neurophysiology, Neurodevelopmental Disabilities, and Epilepsy.
Department Of Neurology
Alexander Rotenberg is a Neurologist practicing medicine in Boston, Massachusetts. Dr. Rotenberg is rated as an Elite provider by MediFind in the treatment of Succinic Semialdehyde Dehydrogenase Deficiency. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Seizures, Succinic Semialdehyde Dehydrogenase Deficiency, Epilepsy, Generalized Tonic-Clonic Seizure, and Deep Brain Stimulation.
Itay Latzer-Tokatly practices practicing medicine in Tel Aviv, Israel. Mr. Latzer-Tokatly is rated as a Distinguished expert by MediFind in the treatment of Succinic Semialdehyde Dehydrogenase Deficiency. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Succinic Semialdehyde Dehydrogenase Deficiency, Epilepsy, Seizures, and Primary Lateral Sclerosis.
Summary: Succinic Semialdehyde Dehydrogenase deficiency (SSADHD) is a rare autosomal recessive disease that interferes with the catabolism of the major inhibitory neurotransmitter gamma-amino butyric acid (GABA) and furthermore leads to accumulation of various potential toxic metabolites, most prominently gamma hydroxybutyric acid (GHB). Current research indicates that there is developmental delay and sign...